Precision population healthcare and beyond…
Life sciences need revolutionary precision insights to drive the future
C2-Ai provides unique insights across 100% of patients at a level of detail and scale that has never been seen in life sciences.
C2-Ai is a leading company in the field of AI-backed healthcare analytics, committed to expanding the use of these powerful technologies in the life sciences industry for the benefit of patients. Our aim is to push the boundaries of what is possible with AI and machine learning, and we believe that these technologies have the potential to transform the way that treatments are developed and delivered. We offer cutting-edge tools and services to help our clients achieve success in their projects.
One key area where we are developing our expertise is in supporting research, development, and delivery of new treatments and therapies. We believe that AI and machine learning have the potential to revolutionize medical research and treatments, allowing for more targeted and equitable approaches that can match specific population needs geographically, socially, and ethnically.
One key area where we are developing our expertise is in supporting research, development, and delivery of new treatments and therapies. We believe that AI and machine learning have the potential to revolutionize clinical research and treatments, allowing for more targeted and equitable approaches that can match specific population needs geographically, socially, and ethnically.
SUPPORTING LIFE SCIENCES
Our suite of tools and services is designed to provide life sciences companies with the insights and support they need to achieve these goals. We offer personalized risk-adjustment tools that enable accurate analysis of patient outcomes and hospital performance. Additionally, we have forward-looking applications that can help to triage and manage patients more effectively.
We have demonstrated their effectiveness in wider applications in Primary and community-based care, supporting health systems, to understand the impacts of their projects and services. We have also expanded our offerings to support the precision population health agenda, with tools that can be used in primary and community care to understand and optimize service planning and configuration.
TRANSFORMING THE FUTURE OF LIFE SCIENCES – TOGETHER
In conclusion, at C2-Ai, we are passionate about the transformative power of AI and machine learning in the life sciences industry to benefit patients. Our suite of cutting-edge tools and services is designed to help our clients achieve success in their projects, whether it be in secondary care, public and population health,or precision medicine. We are committed to pushing the boundaries of what is possible with AI and machine learning and to supporting the development and delivery of new treatments and therapies that can benefit diverse populations of people worldwide.
Join us in this exciting journey to revolutionize the life sciences industry with the power of AI and machine learning.
Talk to our Life Sciences team
Get In TouchRecent awards and recognition
Recent awards and recognition
Globally unique systems to transform healthcare…
Built by clinicians with globally recognised expertise in patient safety and clinical cost effectiveness
AI-backed platform covering 100% of patients across acute care (medicine, surgery, mat/neo, nursing based care) and beyond
No software integration or changes to clinical workflows required
Globally unique systems to transform healthcare…
Built by clinicians with globally recognised expertise in patient safety and clinical cost effectiveness
AI-backed platform covering 100% of patients across acute care (medicine, surgery, mat/neo, nursing based care) and beyond
No software integration or changes to clinical workflows required
Unique capabilities performing truly ground-breaking analysis…
900%
more issues detected across hospitals – clearly actionable for in-year ROI
9*10^453
permutations per patient delivering clincial risk assessment with exceptional accuracy – validated and published
3,300
AI-enhanced discrete metrics that matter – uncovering even hidden issues (failures to respond, omissions to treat)
Unique capabilities performing truly ground-breaking analysis…
900%
more issues detected across hospitals – clearly actionable for in-year ROI
9 × 10⁴⁵³
permutations per patient delivering clincial risk assessment with exceptional accuracy – validated and published
3,300
AI-enhanced discrete metrics that matter – uncovering even hidden issues (failures to respond, omissions to treat)
Successfully delivering meaningful outcomes and insights…
$20m+
Potential direct cost savings per hospital (recurring per annum)
Unique
complication metrics for medical patients
8%
Reduction in emergency admissions
6-20,000
years of surgeon time served (NHS at 100% scale)
125
bed-days saved per 1,000 patients
50%+
reduction in Hospital Acquired Pneumonia/AKI
Successfully delivering meaningful outcomes and insights…
$20m+
Potential direct cost savings per hospital (recurring per annum)
Unique
complication metrics for medical patients
8%
Reduction in emergency admissions
6-20,000
years of surgeon time served (NHS at 100% scale)
125
bed-days saved per 1,000 patients
50%+
reduction in Hospital Acquired Pneumonia/AKI
Based on decades of research and extensive hospital data
450m+
patient records processed from 46 countries
30yrs
of research and 15 years of real world deployment across 11 countries
30%
adoption in NHS ICS regions as well as government + regulators + ‘for profit’ hospitals in US
Based on decades of research and extensive hospital data
400m+
patient records processed from 46 countries
30yrs
of research and 15 years of real world deployment across 11 countries
30%
adoption in NHS ICS regions as well as government + regulators + ‘for profit’ hospitals in US
[sp_wpcarousel id=”6545″]